Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
ANDA Approval Decline Continues, But Why?
Jul 26 2021
•
By
Derrick Gingery
What does the decline in ANDA approvals and complete response letters issued say about the FDA generics program? • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Biosimilars & Generics